October 30, 2020 — BrainFx, a leading digital cognitive functional assessment platform, and Maple, Canada’s leading virtual care provider, have entered into a partnership to expand Canadians’ access to cognitive functional assessments for neurofunctional health.
The COVID-19 pandemic has disrupted traditional models of care and accelerated the shift towards greater accessibility and convenience through virtual care delivery. The pandemic has also impacted the health and wellness of Canadians, particularly as it relates to neurofunctional health. Neurological conditions such as Traumatic Brain Injuries (TBI) and Alzheimer’s continue to be meaningful issues for Canadians; and both COVID-19 and changes to daily life such as increased social isolation have emerged as new and growing areas of challenge from a neurological perspective.
BrainFx and Maple have committed to ensuring that Canadians can continue to get timely, convenient and reliable access to high-quality, evidence-based clinical assessments of cognitive function during this time. By integrating these innovative technologies, Canadians can easily connect online to allied health professionals to continue to get much needed assessments and care, and empowers them to both better understand and track their neurofunctional health.
For more information on BrainFx, visit www.brainfx.com.
To learn more about Maple, visit www.getmaple.ca
About Maple
Maple is a technology platform that tackles some of the world’s most meaningful issues in healthcare, starting with timely and convenient access to doctors and other healthcare providers including dermatologists, psychiatrists, and oncology navigation experts. It allows patients to connect directly with doctors and specialists for medical care in minutes from their smartphone or computer 24/7, and also provides custom technology solutions for employers, insurers, hospitals, and clinics. Learn more at www.getmaple.ca.
About BrainFx
BrainFx develops digital, neurofunctional assessments tools to detect the milder forms of cognitive dysfunction that other tests can miss. BrainFx’s mission is to improve the quality of life of those living with brain disorders globally by making the invisible effects of brain disorders visible. By combining research with technology and clinical knowledge, BrainFx assessments deliver unique insights to health care teams across the continuum of care and help answer ‘What Next?’ to make a difference in health outcomes. For more information, visit www.brainfx.com
